FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/087941 [Registered on: 30/05/2025] Trial Registered Prospectively
Last Modified On: 28/05/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Other 
Public Title of Study   Clinical study to Know the effect of Matra basti with Sapta prastha Mahamashadi Tailam and Vishwadya guggulu in the Treatment of Kampavata wsr to Parkinsons disease 
Scientific Title of Study   An open labelled non-randomized clinical study to evaluate the effect of Matra Basti with Sapta Prastha Mahamashadi Tailam and Vishwadya Guggulu (oral) in the management of Kampavata w.s.r. to Parkinson’s disease 
Trial Acronym  PD 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Smeetha Havaragi 
Designation  Post Graduate in Kayachikitsa 
Affiliation  Dr.BRKR Govt Ayurveda Medical college 
Address  Dr.BRKR Govt Ayurveda Medical college,opposite to ESI Hospital AG colony road Sr nagar Erragadda Hyderabad.

Hyderabad
TELANGANA
500018
India 
Phone  9900734897  
Fax    
Email  havaragismeeta@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr P Srikanth Babu 
Designation  PG Professor and Guide MD Ayurveda Department of Kayachikitsa 
Affiliation  Dr.BRKR Govt Ayurveda Medical college 
Address  Dr.BRKR Govt Ayurveda Medical college,opposite to ESI Hospital AG colony road Sr nagar Erragadda Hyderabad
Dr.BRKR Govt Ayurveda Medical college,opposite to ESI Hospital AG colony road Sr nagar Erragadda Hyderabad
Hyderabad
TELANGANA
500018
India 
Phone  9849463878  
Fax    
Email  drperugu@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr P Srikanth Babu 
Designation  PG Professor and Guide MD Ayurveda Department of Kayachikitsa 
Affiliation  Dr.BRKR Govt Ayurveda Medical college 
Address  Dr.BRKR Govt Ayurveda Medical college,opposite to ESI Hospital AG colony road Sr nagar Erragadda Hyderabad.

Hyderabad
TELANGANA
500018
India 
Phone  9849463878  
Fax    
Email  drperugu@gmail.com  
 
Source of Monetary or Material Support  
DR.BRKR GOVT AYURVEDA MEDICAL COLLEGE OPPO TO ESI HOSPITAL AG COLONY ERRAGADDA SR NAGAR HYDERABAD 
 
Primary Sponsor  
Name  Dr.Smeetha Havaragi 
Address  DR.BRKR GOVT AYURVEDA MEDICAL COLLEGE OPPO TO ESI HOSPITAL AG COLONY ERRAGADDA SR NAGAR HYDERABAD 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
DrSMEETHA HAVARAGI  DR.BRKR GOVT AYURVEDA MEDICAL COLLEGE OPPO TO ESI HOSPITAL AG COLONY ERRAGADDA SR NAGAR HYDERABAD 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Smeetha Havaragi  Dr BRKR Government Ayurveda Hospital Eragadda Hyderabad.  OPD Room NO 1,2,3 Department of Kayachikitsa Dr BRKR Government Ayurveda Hospital Eragadda Hyderabad.
Hyderabad
TELANGANA 
9900734897

havaragismeeta@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committe of Dr.B.R.K.R Government Ayurvedic Medical College and Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:G20||Parkinsons disease. Ayurveda Condition: KAMPAH/VEPATHUH (KEVALAVATA),  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Viswadya Guggulu, Reference: Brihath Nigantu Ratnakar, Route: Oral, Dosage Form: Guggulu , Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: -Sukoshna jala), Additional Information: -
2Intervention ArmProcedure-mAtrAbastiH, मात्राबस्तिः (Procedure Reference: Chakradatta, Procedure details: Patient is lied in left lateral position immediately after food in morning , Then Medicated oil about of 60ml quantity is injected through rectal route for first 7 days for 3 months ( 3 cycles of basti in 90 days ) )
(1) Medicine Name: Sapta Prastha Mahamashadi tailam, Reference: Chakradatta, Route: Rectal, Dosage Form: Taila, Dose: 60(ml), Frequency: od, Duration: 7 Days
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1 Patient who are having signs and symptoms of Kampavata (Parkinson s Disease)
2 Patients of both Gender aged between 30 to 65 years irrespective of work and socioeconomic status
3 Patients indicated for Basti Karma
4Patients willing to give informed consent for the study

 
 
ExclusionCriteria 
Details  1 Below 30 years and Above 65 years
2 Pregnant and Lactating Mothers
3 Patient having severe heart disease malignancy uncontrolled Diabetes mellitus and Hypertension
4 Patient associated with major Neurological problems like Spinal cord injury Multiple system atrophy CVA (hemorrhage and infarct) Alzheimer s disease
5 Patient contraindicated for Basti karma
6 Patient not willing to give informed consent for the study
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement in symptoms and Quality of living  90 days 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in symptoms and Quality of living   90 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   08/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  08/06/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [havaragismeeta@gmail.com].

  6. For how long will this data be available start date provided 08-06-2025 and end date provided 08-12-2026?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - Nil
Brief Summary   Title of study is An open labelled non-randomized clinical study to evaluate the effect of Matra Basti with Sapta Prastha Mahamashadi Tailam and Vishwadya Guggulu oral in the management of Kampavata wsr to Parkinsons disease
1 Vishwady guggulu 500mg tab BD  is given oral route after food  for 90 days
2.Matrabasti with Sapta prasatha Mahamashadi tailam is given for first  7 days for 3 months immediately after food in the Morning
 
Close